Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Open in API
Filings indexed 1,569 across all filing types
Latest filing 2023-04-25 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
NOTIFICATION LETTER AND CHANGE REQUEST FORM TO REGISTERED HOLDER
Report Publication Announcement Classification · 100% confidence The document is a notification letter from Sisram Medical Ltd dated April 26, 2023, informing shareholders about the publication of the 2022 Annual Report. It provides details on how to access the report online and how to request printed copies. The document includes a Change Request Form for shareholders to select their preferred method of receiving future corporate communications. The text explicitly states that the actual 2022 Annual Report is available on the company's website and the HKEXnews website, indicating that this document itself is not the Annual Report but a notification of its publication. The document length is 8640 characters, which is relatively short and consistent with a notification letter rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Report Publication Announcement (RPA) rather than the Annual Report (10-K).
2023-04-25 English
2022 ANNUAL REPORT
Annual Report Classification · 100% confidence The document is titled '2022 Annual Report' and includes comprehensive sections typical of an annual report: Financial Summary, Chairman's Statement, CEO Review, Management Discussion and Analysis, Report of the Directors, Corporate Governance Report, Biographical Details of Directors and Senior Management, Independent Auditor's Report, Consolidated Financial Statements, Notes to Financial Statements, and an Environmental, Social and Governance Report. The content covers full financial performance, business strategy, market conditions, and detailed financial data for the fiscal year ended December 31, 2022. The document length is substantial (15,000 characters), indicating it is the full report rather than an announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2022
2023-04-25 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Sisram Medical Ltd regarding the acceptance of a drug registration application by the National Medical Products Administration in China. It discusses sublicensing rights and product details but does not contain financial data, regulatory certifications, or meeting materials. The document is relatively short (2634 characters) and serves as an update on a business development rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is best classified as a general regulatory announcement about a business event, which fits the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other specific categories.
2023-04-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 March 2023. It details movements in authorised/registered share capital, issued shares, convertibles, and confirms compliance with listing rules. The content focuses on share capital changes and confirmations related to securities issued, typical of regulatory compliance filings to the stock exchange. It does not contain financial statements, management discussion, or earnings data. It is not an announcement of a report but a regulatory return submission. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-04-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 March 2023. It details movements in authorised/registered share capital, issued shares, and confirms no changes in share options, warrants, convertibles, or other agreements. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance movements for a specific month. It is not a financial report, earnings release, or management discussion, but a regulatory filing about share capital movements. The document length is 4433 characters, which is relatively short and consistent with a regulatory filing. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-04-04 English
DISCLOSEABLE TRANSACTION - PROPOSED ACQUISITION OF BUSINESS
M&A Activity Classification · 95% confidence The document is an announcement by Sisram Medical Ltd regarding a discloseable transaction involving the proposed acquisition of a business. It details the terms of the acquisition, including the asset purchase agreement, consideration, payment terms, completion conditions, and governance arrangements. The content focuses on the transaction specifics, financial terms, and regulatory implications under the Hong Kong Listing Rules. There is no indication that this is a full financial report, audit report, earnings release, or other types of filings such as management reports or investor presentations. The document is a formal announcement of a material transaction, which fits the category of M&A Activity (TAR) filings, which cover announcements and documents related to merger proposals or takeover bids. The length and detail confirm it is not a brief announcement or a report publication notice, but a substantive transaction announcement.
2023-03-30 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.